News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Sergio Cifuentes Canaval: Comparative Table of Pembrolizumab Trials in HCC
Photo: Depositphotos
Aug 5, 2025, 11:47

Sergio Cifuentes Canaval: Comparative Table of Pembrolizumab Trials in HCC

Sergio Cifuentes Canaval, Medical Oncologist, ASCO International Development and Education Award (IDEA) Recipient – 2025 at Conquer Cancer, the ASCO Foundation, shared a post on X:

“Comparative Table of Pembrolizumab Trials in HCC

Key Takeaways

Only KEYNOTE-224 (Phase II) met its primary endpoint (ORR), but with low clinical impact (ORR 16%).

Both phase III trials (KEYNOTE-240, LEAP-002) failed their primary OS endpoints despite:

  • Nominal OS improvements (HR <1)
  • Higher ORR in combo arm (LEAP-002)

Context vs. Competitors:

  • Atezo+Bev (IMbrave150): Positive OS (HR 0.66, p<0.001)
  • Tremeli+Durva (HIMALAYA): Positive OS (HR 0.78, p=0.003)

Conclusion:

Pembro-based regimens consistently underdelivered in HCC pivotal trials, failing to demonstrate statistically significant survival benefits in phase III settings.”

Sergio Cifuentes Canaval: Comparative Table of Pembrolizumab Trials in HCC

More posts featuring Sergio Cifuentes Canaval.

cancer GI oncology HCC liver cancer OncoDaily Oncology pembrolizumab Sergio Cifuentes Canaval
Special Coverage
Science
Aug 25, 2025, 09:45
Myeloma Paper of the Day, August 25th, Suggested by Robert Orlowski
Voices
Aug 25, 2025, 09:35
Abdu Adem Yesufe: SPHMMC LINAC Installation Is Complete - A Milestone for Patient Care
Techology
Aug 25, 2025, 09:21
Olivier Elemento: A New Paradigm for Data Interaction - Combining Voice and Augmented Reality
Voices
Aug 25, 2025, 09:09
Caryn Lerman: USC Norris Showcases Future Leaders in Cancer Research
Positive
Aug 25, 2025, 09:01
Joanna Metzner-Sadurski: Historic 50 Million Dollar Anonymous Gift to the Medical University of South Carolina
Voices
Aug 25, 2025, 08:49
Narjust Florez: Boston City Councilor Explores the EQUAL Lung Cancer Screening Study
Voices
Aug 25, 2025, 08:46
Vivek Subbiah: Health-Related Quality of Life in KRASG12C-Mutated Colorectal Cancer
Dialogues
Aug 25, 2025, 06:21
Balstilimab and Botensilimab insights with Dr Benjamin Shelchter - Latest MSS CRC Data from ESMO GI
Voices
Aug 24, 2025, 21:47
Pat Garcia-Gonzalez: One Year of Breast Cancer Program Success in Kenya
Voices
Aug 24, 2025, 21:22
Gustavo Viani: Time to Rethink Brain Metastasis Management
Career Updates
Aug 24, 2025, 19:55
Evelyn Wong is Starting a New Position as Senior Clinical Fellow at University College London Hospitals NHS Foundation Trust
Voices
Aug 24, 2025, 19:46
Haimanot Kasahun: Reflections on Ethiopia’s Radiation Expansion Journey